Cargando…
Silibinin ameliorates hepatic lipid accumulation and oxidative stress in mice with non-alcoholic steatohepatitis by regulating CFLAR-JNK pathway
Non-alcoholic steatohepatitis (NASH) is a chronic metabolic syndrome and the CFLAR-JNK pathway can reverse the process of NASH. Although silibinin is used for the treatment of NASH in clinical, its effect on CFLAR-JNK pathway in NASH remains unclear. This study aimed to investigate the effect of sil...
Autores principales: | Liu, Yayun, Xu, Wei, Zhai, Ting, You, Jiaojiao, Chen, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664044/ https://www.ncbi.nlm.nih.gov/pubmed/31384535 http://dx.doi.org/10.1016/j.apsb.2019.02.006 |
Ejemplares similares
-
Honokiol Alleviates Methionine-Choline Deficient Diet-Induced Hepatic Steatosis and Oxidative Stress in C57BL/6 Mice by Regulating CFLAR-JNK Pathway
por: Zhai, Ting, et al.
Publicado: (2020) -
Silibinin Ameliorates O-GlcNAcylation and Inflammation in a Mouse Model of Nonalcoholic Steatohepatitis
por: Lee, Su Jin, et al.
Publicado: (2018) -
Antioxidant and Hepatoprotective Effects of Silibinin in a Rat Model of Nonalcoholic Steatohepatitis
por: Haddad, Yara, et al.
Publicado: (2011) -
Silibinin Ameliorates Formaldehyde-Induced Cognitive Impairment by Inhibiting Oxidative Stress
por: Wei, Pengsheng, et al.
Publicado: (2022) -
Silibinin alleviates intestinal inflammation via inhibiting JNK signaling in Drosophila
por: Yan, La, et al.
Publicado: (2023)